DaVita HealthCare Partners Inc (DVA) : Gvo Asset Management Ltd reduced its stake in DaVita HealthCare Partners Inc by 3.59% during the most recent quarter end. The investment management company now holds a total of 698,575 shares of DaVita HealthCare Partners Inc which is valued at $54,146,548 after selling 26,000 shares in DaVita HealthCare Partners Inc , the firm said in a disclosure report filed with the SEC on Jul 14, 2016.DaVita HealthCare Partners Inc makes up approximately 6.08% of Gvo Asset Management Ltd’s portfolio.
Other Hedge Funds, Including , Baxter Bros Inc reduced its stake in DVA by selling 30 shares or 0.16% in the most recent quarter. The Hedge Fund company now holds 18,918 shares of DVA which is valued at $1,476,928. DaVita HealthCare Partners Inc makes up approx 0.46% of Baxter Bros Inc’s portfolio.Nexus Investment Management boosted its stake in DVA in the latest quarter, The investment management firm added 2,825 additional shares and now holds a total of 243,500 shares of DaVita HealthCare Partners Inc which is valued at $19,010,045. DaVita HealthCare Partners Inc makes up approx 3.57% of Nexus Investment Management’s portfolio.New England Research Management reduced its stake in DVA by selling 3,250 shares or 39.04% in the most recent quarter. The Hedge Fund company now holds 5,075 shares of DVA which is valued at $387,578. DaVita HealthCare Partners Inc makes up approx 0.34% of New England Research Management’s portfolio.
DaVita HealthCare Partners Inc closed down -0.22 points or -0.28% at $77.51 with 7,04,691 shares getting traded on Monday. Post opening the session at $77.7, the shares hit an intraday low of $77.18 and an intraday high of $77.92 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, DaVita HealthCare Partners Inc reported $0.92 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.87. The company had revenue of $3581.00 million for the quarter, compared to analysts expectations of $3495.91 million. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.86 EPS.
DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.